ZA925764B - Process for preparing virus-inactivated immunglobulin solutions - Google Patents

Process for preparing virus-inactivated immunglobulin solutions

Info

Publication number
ZA925764B
ZA925764B ZA925764A ZA925764A ZA925764B ZA 925764 B ZA925764 B ZA 925764B ZA 925764 A ZA925764 A ZA 925764A ZA 925764 A ZA925764 A ZA 925764A ZA 925764 B ZA925764 B ZA 925764B
Authority
ZA
South Africa
Prior art keywords
inactivated
solutions
immunglobulin
preparing virus
virus
Prior art date
Application number
ZA925764A
Other languages
English (en)
Inventor
Werner Gehringer
Gehringer Werner
Patrick Selosse
Selosse Patrick
Original Assignee
Octapharma A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6437560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA925764(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma A G filed Critical Octapharma A G
Publication of ZA925764B publication Critical patent/ZA925764B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA925764A 1991-08-02 1992-07-31 Process for preparing virus-inactivated immunglobulin solutions ZA925764B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125625A DE4125625C2 (de) 1991-08-02 1991-08-02 Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen

Publications (1)

Publication Number Publication Date
ZA925764B true ZA925764B (en) 1993-04-28

Family

ID=6437560

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925764A ZA925764B (en) 1991-08-02 1992-07-31 Process for preparing virus-inactivated immunglobulin solutions

Country Status (14)

Country Link
US (1) US5648472A (xx)
EP (1) EP0525502B2 (xx)
JP (1) JP2969310B2 (xx)
KR (1) KR100188448B1 (xx)
AT (1) ATE143812T1 (xx)
CZ (1) CZ291813B6 (xx)
DE (2) DE4125625C2 (xx)
DK (1) DK0525502T4 (xx)
ES (1) ES2092604T5 (xx)
FI (1) FI107122B (xx)
IL (1) IL102525A (xx)
SK (1) SK280680B6 (xx)
YU (1) YU48242B (xx)
ZA (1) ZA925764B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
ATE224203T1 (de) † 1997-10-23 2002-10-15 Mitsubishi Pharma Corp Bei raumtemperatur lagerfähiges immunoglobolin- präparat für intravenöse injektion
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
DK1476201T3 (da) 2002-02-19 2009-03-30 Resolution Chemicals Ltd Solvent-baseret sterilisering af steroider
DK1654284T3 (da) * 2003-08-12 2009-07-20 Octapharma Ag Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
WO2005082937A2 (en) 2004-02-27 2005-09-09 Octapharma Ag A method of providing a purified, virus safe antibody preparation
FR2944281B1 (fr) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique Derives soufres de resorcinol, leur preparation et leurs utilisations cosmetiques
WO2019055463A1 (en) * 2017-09-18 2019-03-21 Bayer Healthcare Llc METHODS OF INACTIVATING VIRUSES USING N-METHYLGLUCAMIDE AND ITS DERIVATIVES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography

Also Published As

Publication number Publication date
IL102525A (en) 2005-05-17
IL102525A0 (en) 1993-01-14
DK0525502T4 (da) 2005-09-19
SK236992A3 (en) 1995-01-05
JPH05202100A (ja) 1993-08-10
JP2969310B2 (ja) 1999-11-02
ES2092604T3 (es) 1996-12-01
DE4125625C2 (de) 1999-12-02
DE4125625A1 (de) 1993-02-04
ES2092604T5 (es) 2006-03-01
FI923425A (fi) 1993-02-03
SK280680B6 (sk) 2000-06-12
EP0525502B1 (de) 1996-10-09
FI923425A0 (fi) 1992-07-29
DE59207324D1 (de) 1996-11-14
CZ291813B6 (cs) 2003-06-18
KR100188448B1 (ko) 1999-06-01
EP0525502A1 (de) 1993-02-03
KR930004329A (ko) 1993-03-22
FI107122B (fi) 2001-06-15
US5648472A (en) 1997-07-15
YU48242B (sh) 1997-08-22
ATE143812T1 (de) 1996-10-15
EP0525502B2 (de) 2005-08-10
DK0525502T3 (da) 1997-03-17
CZ236992A3 (en) 1993-02-17
YU74092A (sh) 1995-10-24

Similar Documents

Publication Publication Date Title
ZA925764B (en) Process for preparing virus-inactivated immunglobulin solutions
EP0675198A4 (en) GENES IDENTIFY THE STERILE PLANT CYTOPLASMA AND METHOD FOR PRODUCING HYBRID PLANTS BY USE THEREOF.
EP0475883A3 (en) Method for stabilizing complex composite preforms
HU9201130D0 (en) Multifunctional, water dispergeable cristallizing substance
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
EP0572957A3 (en) Process for the preparation of powdery, anionic surfactants.
EP0610563A3 (en) Semiconductor ingot machining method.
GB8730221D0 (en) Butt-welded cans & process for manufacturing same
HUT56492A (en) Process for producing 3-arylcarbonyl-1-aminoalkyl-1h-indole derivatives and pharamceutical compositions comprising such compounds, against glaucoma
HUT56356A (en) Process for producing thiazolidin-4-ones and 1,3-oxathiolan-5-one derivatives
HU9202349D0 (en) 8-vinyl-quinolone acids, 8-ehinyl-quinolone ones and method for producing said compounds
ZA932843B (en) A method of producing a factor VIII preparation
EP0582277A3 (en) Process for the production of unsaturated alcohols.
ES8505820A1 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
EP0543010A4 (en) MANUFACTURING PROCEDURE OF RING-SHAPED PARTS.
EP0453571A4 (en) METHOD FOR CORRECTING THE POSITION VARIATIONS OF A MACHINE.
EP0599142A3 (de) Verfahren zur Herstellung von Immunkonjugaten.
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
EP0470573A3 (en) Method for the treatment of fluor-containing wastes
EP0475201A3 (en) Process for granulating 2,2,6,6-tetramethylpiperindine-containing light stabilizer
EP0576834A3 (en) Process for the preparation of optically active 1,2-diol derivatives.
EP0301468A3 (en) Process for fabricating complementary contactless vertical bipolar transistors
EP0588032A3 (en) Process for forming implanted regions with lowered channeling risk on semiconductors
EP0302122A4 (en) PROCESS FOR THE PREPARATION OF UNSATURATED QUATERNARY AMMONIUM SALTS.
EP0065174A3 (en) Thyristor having controllable emitter shortings and shorted regions, and process for its operation